Global Patent Index - EP 1735001 A2

EP 1735001 A2 20061227 - PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES COMPRISING A COMBINATION OF EPINASTINE AND ONE OR MORE ADDITIONAL MINERALS OR ONE OR MORE CRUDE DRUGS

Title (en)

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES COMPRISING A COMBINATION OF EPINASTINE AND ONE OR MORE ADDITIONAL MINERALS OR ONE OR MORE CRUDE DRUGS

Title (de)

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON HAUTERKRANKUNGEN MIT EINER KOMBINATION AUS EPINASTIN UND EIN ODER MEHR ZUSÄTZLICHEN MINERALIEN ODER EIN ODER MEHR ROHARZNEIMITTELN

Title (fr)

COMPOSITIONS PHARMACEUTIQUES DESTINEES AU TRAITEMENT DE MALADIES DE LA PEAU CONTENANT UNE COMBINAISON D'EPINASTINE ET D'UN OU PLUSIEURS MINERAUX OU D'UNE OU PLUSIEURS MATIERES PREMIERES

Publication

EP 1735001 A2 20061227 (EN)

Application

EP 05716230 A 20050319

Priority

  • EP 2005002947 W 20050319
  • EP 04007079 A 20040324
  • EP 04007080 A 20040324
  • EP 05716230 A 20050319

Abstract (en)

[origin: WO2005089803A2] The present invention relates to pharmaceutical compositions for the treatment of skin diseases. Particularly, the compositions described in the present invention are highly effective for the treatment of skin diseases associated with allergic reactions among a variety of symptoms derived from skin diseases. These compositions comprise an antihistaminic-effective amount of epinastine or a pharmaceutically acceptable salt thereof and one or more additional pharmaceutically acceptable minerals or one or more pharmaceutically acceptable crude drugs. The compositions may also comprise pharmaceutically acceptable additives.

IPC 8 full level

A61K 45/06 (2006.01); A61K 31/5517 (2006.01); A61K 33/00 (2006.01); A61K 36/076 (2006.01); A61K 36/23 (2006.01); A61K 36/233 (2006.01); A61K 36/234 (2006.01); A61K 36/25 (2006.01); A61K 36/282 (2006.01); A61K 36/346 (2006.01); A61K 36/484 (2006.01); A61K 36/538 (2006.01); A61K 36/575 (2006.01); A61K 36/634 (2006.01); A61K 36/708 (2006.01); A61K 36/736 (2006.01); A61K 36/744 (2006.01); A61K 36/8994 (2006.01); A61K 36/90 (2006.01); A61K 36/9068 (2006.01); A61P 17/00 (2006.01)

CPC (source: EP)

A61K 31/5517 (2013.01); A61K 33/00 (2013.01); A61K 36/076 (2013.01); A61K 36/23 (2013.01); A61K 36/233 (2013.01); A61K 36/234 (2013.01); A61K 36/25 (2013.01); A61K 36/282 (2013.01); A61K 36/346 (2013.01); A61K 36/484 (2013.01); A61K 36/538 (2013.01); A61K 36/575 (2013.01); A61K 36/634 (2013.01); A61K 36/708 (2013.01); A61K 36/736 (2013.01); A61K 36/744 (2013.01); A61K 36/8994 (2013.01); A61K 36/90 (2013.01); A61K 36/9068 (2013.01); A61K 45/06 (2013.01); A61P 17/00 (2018.01); A61P 17/02 (2018.01); A61P 17/04 (2018.01); A61P 17/06 (2018.01); A61P 37/08 (2018.01); A61P 43/00 (2018.01)

C-Set (source: EP)

  1. A61K 31/5517 + A61K 2300/00
  2. A61K 33/00 + A61K 2300/00
  3. A61K 36/076 + A61K 2300/00
  4. A61K 36/23 + A61K 2300/00
  5. A61K 36/233 + A61K 2300/00
  6. A61K 36/234 + A61K 2300/00
  7. A61K 36/25 + A61K 2300/00
  8. A61K 36/282 + A61K 2300/00
  9. A61K 36/346 + A61K 2300/00
  10. A61K 36/484 + A61K 2300/00
  11. A61K 36/538 + A61K 2300/00
  12. A61K 36/575 + A61K 2300/00
  13. A61K 36/634 + A61K 2300/00
  14. A61K 36/708 + A61K 2300/00
  15. A61K 36/736 + A61K 2300/00
  16. A61K 36/744 + A61K 2300/00
  17. A61K 36/8994 + A61K 2300/00
  18. A61K 36/90 + A61K 2300/00
  19. A61K 36/9068 + A61K 2300/00

Citation (search report)

See references of WO 2005089803A3

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

Designated extension state (EPC)

AL BA HR LV MK YU

DOCDB simple family (publication)

WO 2005089803 A2 20050929; WO 2005089803 A3 20061116; AR 049876 A1 20060913; EP 1735001 A2 20061227; JP 2007530481 A 20071101; PE 20051158 A1 20060216

DOCDB simple family (application)

EP 2005002947 W 20050319; AR P050101140 A 20050323; EP 05716230 A 20050319; JP 2007504328 A 20050319; PE 2005000324 A 20050322